Shine-On BioMedical Co.,Ltd. Share Price

Equities

6926

TW0006926009

Biotechnology & Medical Research

End-of-day quote Taipei Exchange 03:30:00 14/06/2024 am IST 5-day change 1st Jan Change
66 TWD +1.69% Intraday chart for Shine-On BioMedical Co.,Ltd. +1.85% -4.90%

Financials

Sales 2022 - Sales 2023 9.52 307.89 795.51 Capitalization 345.61Cr 11TCr 29TCr
Net income 2022 -1.9Cr -61Cr -158.7Cr Net income 2023 -3.7Cr -119.61Cr -309.05Cr EV / Sales 2022 -
Net cash position 2022 116.46Cr 3.77TCr 9.73TCr Net cash position 2023 113.65Cr 3.67TCr 9.49TCr EV / Sales 2023 24,35,56,699 x
P/E ratio 2022
-147 x
P/E ratio 2023
-92.5 x
Employees 19
Yield 2022 *
-
Yield 2023
-
Free-Float 81.15%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.69%
1 week+1.85%
Current month+1.69%
1 month+1.54%
3 months+4.60%
6 months+5.60%
Current year-4.90%
More quotes
1 week
64.80
Extreme 64.8
67.70
1 month
63.10
Extreme 63.1
67.70
Current year
61.10
Extreme 61.1
68.20
1 year
58.50
Extreme 58.5
80.00
3 years
45.00
Extreme 45
93.00
5 years
45.00
Extreme 45
93.00
10 years
45.00
Extreme 45
93.00
More quotes
Date Price Change Volume
14/24/14 66 +1.69% 25,000
13/24/13 64.9 +0.15% 15,500
12/24/12 64.8 -0.46% 12,000
11/24/11 65.1 +0.46% 1,057
07/24/07 64.8 -2.11% 48,303

End-of-day quote Taipei Exchange, June 14, 2024

More quotes
Shine-On BioMedical Co Ltd is a Taiwan-based company mainly engaged in the research, development and manufacture of anti-cancer related new drug products. Antibody products include trispecific T cell engaging nanobody (SOA101), EphA10 trispecific antibody engaging immune cells (SOA201), iNb Intrabody nanoscale intracellular specific antibody drug (SOA102), iNb STAR TriTE T cell receptor Nano-scale trispecific antibody drug (SOA103). Nucleic acid drugs include exosome-carrying nucleic acid and chemotherapy drugs (SOB101).
More about the company